Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets-Reference-Cited by-同舟云学术

Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets

Published:2019-02 Issue:1 Volume:3 Page:e168
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Bizymi Nikoleta,Bjelica Sunčica,Kittang Astrid Olsnes,Mojsilovic Slavko,Velegraki Maria,Pontikoglou Charalampos,Roussel Mikael,Ersvær Elisabeth,Santibañez Juan Francisco,Lipoldová Marie,Papadaki Helen A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference99 articles.

1. History of myeloid derived suppressor cells (MDSCs) in the macro- and micro-environment of tumour-bearing hosts;Talmadge;Nat Rev Cancer.,2013

2. The terminology issue for myeloid-derived suppressor cells;Gabrilovich;Cancer Res.,2007

3. Myeloid-derived suppressor cells;Gabrilovich;Cancer Immunol Res.,2017

4. Myeloid-derived suppressor cells coming of age;Veglia;Nat Immunol.,2018

5. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards;Bronte;Nat Commun.,2016

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid-derived suppressor cells: Implication in myeloid malignancies and immunotherapy;Acta Histochemica;2024-10

2. Comprehensive mapping of immune perturbations associated with secondary hemophagocytic lymphohistiocytosis;Journal of Leukocyte Biology;2024-07-08

3. Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy;Expert Review of Clinical Immunology;2024-05-14

4. Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium;HemaSphere;2024-05

5. CXCL8 secreted by immature granulocytes inhibits wildtype hematopoiesis in chronic myelomonocytic leukemia;2024-03-13